Mediamedic

Your source for medical insights on oncology, infectious diseases, hepatology, and more. Join us in exploring the world of healthcare. 🏥 #MedicalScience"

[Mediamedic @MediaMedic2023]

CUDA 2026 | Prof. Xingyuan Xiao: Rethinking Comprehensive Urologic Cancer Management Through the Integration of Traditional Chinese and Western Medicine and MDT https://t.co/uT0hZXzHJw

https://t.co/GjW2EJ2zM3

#XingyuanXiao #CUDA2026 #Urology #UrologicOncology

[Mediamedic @MediaMedic2023]

CUDA 2026 | Prof. Zhaohui Gu: Advancing Intelligent Surgery and Precision Treatment to Shape the Future of Urology https://t.co/1RuyAx38Cq

https://t.co/1Tysyhlscg

#ZhaohuiGu #CUDA2026 #Urology

[Mediamedic @MediaMedic2023]

Breaking New Ground in Oligometastatic Kidney Cancer | Prof. Liru He’s Team Reports Sunitinib Plus SBRT Strategy in Cell Reports Medicine https://t.co/HJEb80uFzQ

https://t.co/cCjTRUSabG

#LiruHe #RenalCellCarcinoma #KidneyCancer

[Mediamedic @MediaMedic2023]

19th CUA Genitourinary Oncology Conference | Professor Baojun Wang: Breaking Through the Bottlenecks in Prostate Cancer Treatment—Balancing Clinical Innovation with Standardized Care https://t.co/xaX3QLOljV

https://t.co/HVKXwLEwTG

#BaojunWang #CUA2026 #ProstateCancer

[Mediamedic @MediaMedic2023]

19th CUA Genitourinary Oncology Conference | Professor Xuesong Li: Advancing the UTUC Subspecialty Through High-Quality Research to Address Key Clinical Challenges https://t.co/a4ZCbvQvMa

https://t.co/Cx25NCvqky

#XuesongLi #CUA2026 #UTUC #UrologicOncology

[Mediamedic @MediaMedic2023]

19th CUA Genitourinary Oncology Conference | Professor Kan Gong: Taking a Pragmatic View of AI in Clinical Practice While Building a China-Specific Evidence Base for Urologic Oncology https://t.co/hDmSPZAzdp

https://t.co/usj438xE5D

#KanGong #CUA2026 #UrologicOncology

[Mediamedic @MediaMedic2023]

CUDA 2026 | Professor Xuepei Zhang: Advancing High-Quality Urologic Care and Regional Collaboration from Zhengzhou https://t.co/NdcWA78gQh

https://t.co/bHczp6MLM9

#XuepeiZhang #CUDA2026 #Urology #ClinicalInnovation

[Mediamedic @MediaMedic2023]

Professor Lianqu Wang: Leveraging a Century of Medical Education and Regional Healthcare Strengths to Advance Integrated Clinical Care, Education, and Research in Urology at Henan University https://t.co/QumVFFqFpL

https://t.co/kaFoa4qQDd

#LianquWang #CUDA2026 #Urology

[Mediamedic @MediaMedic2023]

CUDA 2026 | Professor Linhui Wang: Advancing Precision Kidney-Sparing Surgery in the Modern Era of Renal Cancer Care https://t.co/DAC0JLrOID

https://t.co/P9I1KtF4uK

#LinhuiWang #CUDA2026 #RenalCancer #KidneyCancer

[Mediamedic @MediaMedic2023]

Professor Benlong Yang: Breast Surgery Enters the Era of De-escalation and Individualized Care in Precision Oncology | 2026 CACA Cancer Prevention and Screening Conference https://t.co/IBhr0itphQ

https://t.co/83ZGqTt3S7

#BenlongYang #CACA2026 #BreastCancer

[Mediamedic @MediaMedic2023]

Professor Ciqiu Yang: From Small Clinical Observations to Meaningful Discoveries—Why Long-Term Commitment Matters in Clinical Research | Samsung Club https://t.co/E9aXZUW7VR

https://t.co/ovE5Mcydp0
#CiqiuYang #SamsungClub #BreastCancer

[Mediamedic @MediaMedic2023]

Samsung Club | Professor Xin Wang: New Thinking in Breast Cancer Surgery in the Era of Precision Medicine—Less Extensive Surgery, More Powerful Imaging https://t.co/PN6ING06yj

https://t.co/WGONuVS8f0

#XinWang #SamsungClub #BreastCancer

[Mediamedic @MediaMedic2023]

BOC Preview | Professor Zefei Jiang: Gathering in Hohhot to Showcase Global Advances and China’s Annual Achievements in Clinical Oncology https://t.co/eBmgkb3Ox4

https://t.co/K81elDP2rQ

#ZefeiJiang #BOC2026 #BestofCSCO2026 #CSCO

[Mediamedic @MediaMedic2023]

ASCO China Perspective | Professor Benlong Yang: PREPEC Trial Shows Superior Quality of Life with Prepectoral Breast Reconstruction, but Higher Implant Loss Risk Requires Careful Consideration https://t.co/MPb1rTP8jC

https://t.co/UZlyR1b1NH

#ASCO2026 #PREPEC #BreastCancer

[Mediamedic @MediaMedic2023]

Five-Year SENOMAC Results Confirm the Safety of Omitting ALND While Improving Quality of Life, Expanding the Boundaries of Axillary De-escalation https://t.co/T2L3VskSLZ

https://t.co/m3VhYkmufl

#YongshengWang #JanadeBoniface #ASCO2026

[Mediamedic @MediaMedic2023]

ASCO China Perspective | Professor Kun Wang: Seven-Year KEYNOTE-522 Data Reinforce Curative Potential for High-Risk Early TNBC https://t.co/s8AeblTqvk

https://t.co/66iznKQWod

#KunWang #ASCO2026 #KEYNOTE522

[Mediamedic @MediaMedic2023]

ASCO China Perspective | Professor Jia Wang and Dr. Hao Yu: “Faster Is Not Always Better”—New Pooled Analysis Reframes Chemotherapy Strategies for High-Risk HR+/HER2− Early Breast Cancer https://t.co/5mMMoSeTLI

https://t.co/PELP5sityF

#JiaWang #HaoYu #ASCO2026 #BreastCancer

[Mediamedic @MediaMedic2023]

2026 Lingnan Breast Cancer Forum | Ciqiu Yang: Precision Decision-Making for Breast-Conserving Surgery and Axillary Preservation After Neoadjuvant Therapy https://t.co/XST0IzXBaD

https://t.co/6hlpnSUjg4

#CiqiuYang #LingnanBreastCancerForum #BreastCancer

[Mediamedic @MediaMedic2023]

2026 Lingnan Breast Cancer Forum | Professor Kun Wang: Advancing Integrated Prevention and Care Across the Entire Breast Cancer Journey https://t.co/Wnry5U1KK1

https://t.co/ghHLvXJR8U

[Mediamedic @MediaMedic2023]

2026 Beijing Breast Cancer Forum | Professor Shu Wang: Integrating Innovation and Collaboration to Advance High-Quality Breast Surgery https://t.co/UdDCEi909U

https://t.co/Xg4NXGE0QK

#ShuWang #BeijingBreastCancerForum #BreastCancer